Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Drospirenone manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Egypt

Clear all

2 products found

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21898
This company, established in the Middle East over four decades ago, is an investment firm focused on healthcare industries. It primarily manufactures and distributes pharmaceuticals, with a strong presence in Europe, Africa, and the Middle East. Their product line includes both Rx and OTC drugs, covering over 35 therapeutic areas, with a key focus on oncology, cardiology, and other essential medicine categories. Dosage forms include solids, liquids, and injectables. The company is committed to research and development, supporting pharmaceutical industry advancement in the region. Their facilities adhere to EU and US GMP standards, demonstrating their commitment to high-quality production. The company is a major player in the regional market, known for its commitment to affordable and readily accessible healthcare solutions.

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Drospirenone:

Drospirenone, also known under the brand name Slynd, or in combination with oestrogen where it is commonly sold under the name Yasmin, is a progestin medication which is used in birth control pills. These pharmaceutical products are prescribed to prevent pregnancy and are also used in menopausal hormone therapy, along with the treatment of a few other indications.
Drospirenone is known as a fourth-generation progestin, with the original patent being granted to the drugs manufacturing company Schering AG in 1976 and subsequently emerged onto the medical marketplace in 2000. With drospirenone manufacturers and drospirenone suppliers being granted additional patents including WIPO and US in 1998 and 2000, respectively. More recently, the medication was approved for use in menopausal hormone therapy in combination with estradiol in 2005 and was introduced for use as a progestogen-only birth control pill in 2019.
Currently, due to the expiration of patents and its wide regulatory approval, drospirenone has become cost-effective for distributors to list for sale and wholesale on the global marketplace. As such, drospirenone, especially in combination with ethinylestradiol, has become widely available for order at a variety of price points and quantities.

Method of action of drospirenone:

Drospirenone functions through its antiandrogen effects, improving acne and hirsutism, while also inhibiting the maturation of follicles and ovulation, preventing pregnancy. It is an analogue of the diuretic spironolactone, which involves anti-mineralocorticoid activity, inhibiting aldosterone receptors, which increases sodium and water excretion. In essence, drospirenone suppresses the release of both the follicle-stimulating hormone and luteinizing hormone, preventing ovulation, while also inducing other changes which may aid in pregnancy prevention. Such as alterations in cervical mucus consistency, hindering sperm movement, and lowering the chance of embryo implantation.

Form and dosage of drospirenone:

As with other drugs, the final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributor and order. However, drospirenone is predominantly listed for sale as a combination medication along with ethinylestradiol. It comes in forms including tablets and film-coated tablets which are taken orally, with or without food. Typically for use in pregnancy prevention and menstruation regulation, it is recommended that the medication be taken once daily during the 21-day cycle, followed by 7 days abstinence. For the use in the treatment of other indications, drospirenone regimes tend to be bespoke to the needs of the specific patient, as such, the prescribing medical official’s and manufacturers’ instructions should be adhered to.

Drospirenone on Pipelinepharma:

Currently, we have found 13 trusted drospirenone manufacturers and drospirenone suppliers from our online global list of B2B sellers. These distributors have drospirenone available for order online and are located in countries including India, Brazil, the European Union, and Argentina. Each of the manufacturing and B2B wholesale companies on our online pharmaceutical products list has been verified by the Pipelinepharma team according to strict quality control. This ensures a hassle-free sourcing experience and reduces buyer mileage.

Price of drospirenone and how to buy:

Although the cost of drospirenone is highly dependent on numerous factors, a cursory search online reveals a typical B2B wholesale cost at approximately USD 18.92 for 63 tablets of drospirenone at 3 mg and ethinylestradiol at 30 micrograms. These values are for the NHS in the UK, as such are only intended for reference. Finding drospirenone manufacturers and drospirenone suppliers on the Pipelinepharma company marketplace is easy, simply search for the desired pharmaceutical products, select the listing of choice, and then press either the ‘Accept’, ‘Negotiate’, or ‘Get offer’ button on the online interface to begin a transaction.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible